| __timestamp | Amneal Pharmaceuticals, Inc. | Evotec SE |
|---|---|---|
| Wednesday, January 1, 2014 | 84615000 | 17990000 |
| Thursday, January 1, 2015 | 109679000 | 25166000 |
| Friday, January 1, 2016 | 118757000 | 27013000 |
| Sunday, January 1, 2017 | 109046000 | 42383000 |
| Monday, January 1, 2018 | 230435000 | 57012000 |
| Tuesday, January 1, 2019 | 289598000 | 66546000 |
| Wednesday, January 1, 2020 | 326727000 | 77238000 |
| Friday, January 1, 2021 | 365504000 | 105445000 |
| Saturday, January 1, 2022 | 399700000 | 156190000 |
| Sunday, January 1, 2023 | 429675000 | 169610000 |
Data in motion
In the evolving landscape of pharmaceuticals, understanding spending patterns is crucial. From 2014 to 2023, Amneal Pharmaceuticals, Inc. and Evotec SE have shown distinct trajectories in their Selling, General, and Administrative (SG&A) expenses. Amneal's SG&A expenses surged by over 400%, peaking at approximately $430 million in 2023. This reflects a strategic expansion and increased operational activities. In contrast, Evotec SE's SG&A expenses grew by nearly 850%, reaching around $170 million in the same period, indicating a robust scaling of their operations. Notably, Amneal consistently outspent Evotec, highlighting differing business models and market strategies. These trends underscore the dynamic nature of the pharmaceutical industry, where strategic spending is pivotal for growth and competitiveness.
SG&A Efficiency Analysis: Comparing Novartis AG and Amneal Pharmaceuticals, Inc.
Vertex Pharmaceuticals Incorporated vs Evotec SE: SG&A Expense Trends
Selling, General, and Administrative Costs: Zoetis Inc. vs Amneal Pharmaceuticals, Inc.
Selling, General, and Administrative Costs: argenx SE vs Evotec SE
Cost Management Insights: SG&A Expenses for United Therapeutics Corporation and Evotec SE
Operational Costs Compared: SG&A Analysis of Insmed Incorporated and Evotec SE
Selling, General, and Administrative Costs: BioMarin Pharmaceutical Inc. vs Evotec SE
Blueprint Medicines Corporation or Amneal Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: Alkermes plc vs Evotec SE Trends and Insights
Amneal Pharmaceuticals, Inc. or Veracyte, Inc.: Who Manages SG&A Costs Better?
Cost Management Insights: SG&A Expenses for Apellis Pharmaceuticals, Inc. and Evotec SE
Cost Management Insights: SG&A Expenses for Arrowhead Pharmaceuticals, Inc. and Evotec SE